AccessPak for HIV PEP Expanded with Kaletra and Emsam Transdermal
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Emsam Transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: selegiline
Brand name: Emsam, Eldepryl, Zelapar
Synonyms: Emsam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine and tenofovir
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine and Tenofovir Alafenamide
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine and Tenofovir Disoproxil Fumarate
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine and Tenofovir Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Emtricitabine Capsules
- Emsam Transdermal-AccessPak for HIV PEP Expanded with Viracept
- Emsam Transdermal-Accolate
- Emsam Transdermal-Accretropin
- Emsam Transdermal-Accucaine
- Emsam Transdermal-AccuHist Drops
- Emsam Transdermal-AccuHist PDX Drops